Overview

Gender

male

Investor Type

Investment Partner

Thompson is currently a Venture Partner with OrbiMed who brings over 20 years of industry experience. He co-founded and was CEO of Trubion Pharmaceuticals and co-founded Cleave BioSciences. In addition to Principia Biopharma, Dr. Thompson serves on the Boards of Cleave BioSciences, Anthera, Methylgene and Response Biomedical. He was an executive of Chiron Corporation and Becton Dickinson.

Dr. Thompson is an Ernst & Young Entrepreneur of the Year awardee, an Affiliate Professor of Neurosurgery at the University of Washington, an inventor on numerous patents, and a board-certified internist and oncologist. He was on staff at the National Cancer Institute following his internal medicine training at Yale University. Dr. Thompson received ScB and MD degrees from Brown University.